Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Are electrophysiological and oligodendrocyte alterations an element in the development of multiple sclerosis at the same time as or before the immune response?
Ortiz GG, Mireles-Ramírez MA, Pacheco-Moisés FP, Ramírez-Jirano LJ, Bitzer-Quintero OK, Delgado-Lara DLC, Flores-Alvarado LJ, Mora-Navarro MA, Huerta M, Torres-Mendoza BMG. Ortiz GG, et al. Int J Neurosci. 2021 Dec;131(12):1221-1230. doi: 10.1080/00207454.2020.1786087. Epub 2020 Jun 29. Int J Neurosci. 2021. PMID: 32571126 Review.
Role of the blood-brain barrier in multiple sclerosis.
Ortiz GG, Pacheco-Moisés FP, Macías-Islas MÁ, Flores-Alvarado LJ, Mireles-Ramírez MA, González-Renovato ED, Hernández-Navarro VE, Sánchez-López AL, Alatorre-Jiménez MA. Ortiz GG, et al. Arch Med Res. 2014 Nov;45(8):687-97. doi: 10.1016/j.arcmed.2014.11.013. Epub 2014 Nov 26. Arch Med Res. 2014. PMID: 25431839 Review.
Interleukin-17A Levels Vary in Relapsing-Remitting Multiple Sclerosis Patients in Association with Their Age, Treatment and the Time of Evolution of the Disease.
Guerrero-García Jde J, Castañeda-Moreno VA, Torres-Carrillo N, Muñoz-Valle JF, Bitzer-Quintero OK, Ponce-Regalado MD, Mireles-Ramírez MA, Valle Y, Ortuño-Sahagún D. Guerrero-García Jde J, et al. Neuroimmunomodulation. 2016;23(1):8-17. doi: 10.1159/000441004. Epub 2015 Nov 25. Neuroimmunomodulation. 2016. PMID: 26599431 Free article.
Oxidative Stress: Love and Hate History in Central Nervous System.
Ortiz GG, Pacheco Moisés FP, Mireles-Ramírez M, Flores-Alvarado LJ, González-Usigli H, Sánchez-González VJ, Sánchez-López AL, Sánchez-Romero L, Díaz-Barba EI, Santoscoy-Gutiérrez JF, Rivero-Moragrega P. Ortiz GG, et al. Adv Protein Chem Struct Biol. 2017;108:1-31. doi: 10.1016/bs.apcsb.2017.01.003. Epub 2017 Mar 7. Adv Protein Chem Struct Biol. 2017. PMID: 28427557 Review.
[Effect of melatonin administration on cyclooxygenase-2 activity, serum levels of nitric oxide metabolites, lipoperoxides and glutathione peroxidase activity in patients with Parkinson’s disease].
Ortiz GG, Moráles-Sánchez EW, Pacheco-Moisés FP, Jiménez-Gil FJ, Macías-Islas MA, Mireles-Ramírez MA, González-Usigli H. Ortiz GG, et al. Gac Med Mex. 2017;153(Supl. 2):S72-S81. doi: 10.24875/GMM.M000008. Gac Med Mex. 2017. PMID: 29099102 Free article. Clinical Trial. Spanish.
MIF functional polymorphisms (-794 CATT5-8 and -173 G>C) are associated with MIF serum levels, severity and progression in male multiple sclerosis from western Mexican population.
Castañeda-Moreno VA, De la Cruz-Mosso U, Torres-Carrillo N, Macías-Islas MA, Padilla-De la Torre O, Mireles-Ramírez MA, González-Pérez O, Ruiz-Sandoval JL, Huerta M, Trujillo X, Ortuño-Sahagún D, Muñoz-Valle JF. Castañeda-Moreno VA, et al. J Neuroimmunol. 2018 Jul 15;320:117-124. doi: 10.1016/j.jneuroim.2018.04.006. Epub 2018 Apr 10. J Neuroimmunol. 2018. PMID: 29661540
Association between the -844 G>A, HindIII C>G, and 4G/5G PAI-1 Polymorphisms and Susceptibility to Multiple Sclerosis in Western Mexican Population.
Valdés-Alvarado E, Huerta M, Trujillo X, Valle Y, Padilla Gutiérrez JR, Mireles-Ramírez MA, Macías-Islas MA, Luz Margarita BR, Muñoz-Valle JF. Valdés-Alvarado E, et al. Dis Markers. 2019 Oct 7;2019:9626289. doi: 10.1155/2019/9626289. eCollection 2019. Dis Markers. 2019. PMID: 31687051 Free PMC article.
Cognitive disorder and dementia in type 2 diabetes mellitus.
Ortiz GG, Huerta M, González-Usigli HA, Torres-Sánchez ED, Delgado-Lara DL, Pacheco-Moisés FP, Mireles-Ramírez MA, Torres-Mendoza BM, Moreno-Cih RI, Velázquez-Brizuela IE. Ortiz GG, et al. World J Diabetes. 2022 Apr 15;13(4):319-337. doi: 10.4239/wjd.v13.i4.319. World J Diabetes. 2022. PMID: 35582669 Free PMC article. Review.
33 results